Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer

Ang Yuan(Hospital Kuala Lumpur), Pan‐Chyr Yang(Institute of Biomedical Sciences, Academia Sinica), Chong‐Jen Yu(National Taiwan University Hospital), Wen‐Jone Chen(Min Sheng General Hospital), Fang‐Yue Lin(National Taiwan University Hospital), Sow-Hsong Kuo(Institute of Biomedical Sciences, Academia Sinica), Kwen‐Tay Luh(Institute of Biomedical Sciences, Academia Sinica)
International Journal of Cancer
January 1, 2000
10.1002/1097-0215(20001120)89:6<475::aid-ijc2>3.0.co;2-t
Cited by 142

Related Papers

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis
|The Lancet|2008|1.1k
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|The Lancet Oncology|2015|980
Detection and Dynamic Changes of <i>EGFR</i> Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
|Clinical Cancer Research|2015|469